OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

BIOGEN INC/  US09062X1037  /

Vienna Global Market
2024-04-19  5:32:33 PM Chg. -0.55 Volume Bid5:32:33 PM Ask5:32:33 PM Market Capitalization Dividend Y. P/E Ratio
178.80EUR -0.31% 0
Turnover: -		 -Bid Size: - -Ask Size: - 26.52 bill.EUR - -
GlobeNewswire 04-17 Unispace Group announces new EMEA CEO appointment
GlobeNewswire 04-15 Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
GlobeNewswire 04-10 Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
GlobeNewswire 04-02 ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer
GlobeNewswire 04-02 Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
GlobeNewswire 04-01 Autolus Therapeutics Announces Changes to its Board of Directors
GlobeNewswire 03-25 Dyne Therapeutics Announces CEO Transition
GlobeNewswire 03-13 Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer
GlobeNewswire 03-11 Hyku Biosciences, a Covalent Precision Medicine Company, Announces CEO Transition for its Next Phase...
GlobeNewswire 03-08 From the Beach to the Boardroom: Unispace's 'Art for Impact' Program Partners with NGO to Turn 50,00...
GlobeNewswire 03-07 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Biogen Inc. - BI...
GlobeNewswire 03-06 New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) i...
GlobeNewswire 03-06 Genesis Research Group Announces Appointment of David W. Miller as CEO
GlobeNewswire 03-04 Biogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (...
GlobeNewswire 02-28 Promising Pathways to Simplified Alzheimer's Diagnosis Unveiled in Groundbreaking Study
GlobeNewswire 02-27 Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlig...
GlobeNewswire 02-27 Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024
GlobeNewswire 02-24 BIOGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Biogen Inc. on Behalf of Biogen Stockhold...
GlobeNewswire 02-23 Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positiv...
GlobeNewswire 02-22 Neurologists Report Frustration with Efficacy and Logistical Issues Around Eisai/Biogen’s Leqembi, A...
GlobeNewswire 02-22 C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business High...
GlobeNewswire 02-20 Mestag Therapeutics Enlists Leading Cancer Biology and Immunology Advisors to Support Clinical Devel...
GlobeNewswire 02-15 Royalty Pharma Reports Q4 and Full Year 2023 Results
TeleTrader 02-13 US closes lower on disheartening inflation data
TeleTrader 02-13 US opens lower on higher-than-expected CPI number